| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AZD6244 | CTRPv2 | pan-cancer | AAC | 0.006 | 0.9 |
| mRNA | navitoclax:piperlongumine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0059 | 0.9 |
| mRNA | PD173074 | GDSC1000 | pan-cancer | AAC | -0.0057 | 0.9 |
| mRNA | T0901317 | GDSC1000 | pan-cancer | AAC | 0.0052 | 0.9 |
| mRNA | TGX221 | GDSC1000 | pan-cancer | AAC | -0.0075 | 0.9 |
| mRNA | Midostaurin | GDSC1000 | pan-cancer | AAC | 0.0054 | 0.9 |
| mRNA | 968 | CTRPv2 | pan-cancer | AAC | 0.01 | 0.9 |
| mRNA | Talazoparib | GDSC1000 | pan-cancer | AAC | -0.0051 | 0.9 |
| mRNA | QL-VIII-58 | GDSC1000 | pan-cancer | AAC | -0.0068 | 0.9 |
| mRNA | momelotinib | CTRPv2 | pan-cancer | AAC | 0.005 | 0.9 |